ALX Oncology Holdings Inc. ( ALXO) - Key Metrics
ALXO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.13 | -$0.12 | -$0.12 |
| 2026Q1 | $0 | -$0.17 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.42 | -$0.35 | -$0.35 |
| 2025Q3 | $0 | -$0.41 | -$0.32 | -$0.32 |
| 2025Q2 | $0 | -$0.49 | -$0.44 | -$0.44 |
ALXO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.98 |
| 2026Q1 | 0% | -2.96 |
| 2025Q4 | 0% | -0.67 |
| 2025Q3 | 0% | -1.12 |
| 2025Q2 | 0% | -0.21 |
ALXO
Price: $1.96
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 63179
Market Capitalization: 268.3 million